News

March 29, 2017

Cytokinetics Announces Start of Second Cohort in Phase 2 Clinical Trial of CK-2127107 in Patients with SMA

Cytokinetics Announces Start of Second Cohort in Phase 2 Clinical Trial of CK-2127107 in Patients with SMA

Cytokinetics, Inc. today announced that the second cohort of the Phase 2 clinical trial of CK-2127107 in patients with spinal muscular atrophy (SMA), is open to...

READ MORE   |  

Topics: Clinical Trials, Front Page News

March 23, 2017

Cure SMA Coverage and Payment Policy Project Continues to Move Forward

Cure SMA Coverage and Payment Policy Project Continues to Move Forward

The Cure SMA Coverage and Payment Policy Project has two distinct but complementary tracks:

  • Outreach on behalf of our community. We’re working with public and private insurers, regulators, and other stakeholders, advocating for prompt, comprehensive coverage for SMA...

READ MORE   |  

Topics: Advocacy, Front Page News

March 21, 2017

Genentech Roche Releases Community Letter with Clinical Trial Updates

Genentech Roche Releases Community Letter with Clinical Trial Updates

Genentech Roche provided the following community statement with clinical trial updates for SUNFISH (Type 2/3), FIREFISH (Type 1) and JEWELFISH. 

Dear SMA community,

At Genentech (A Member of the Roche Group) we are committed to addressing the urgent needs of...

READ MORE   |  

Topics: Clinical Trials, Front Page News

Items 10 - 12 of 332  Previous12345678910Next

© 2014 Cure SMA | Privacy Policy

Powered by Blackbaud
nonprofit software